KUALA LUMPUR, Feb 16 (Bernama) -- Medidata, a Dassault Systèmes company, announced it is allowing sponsors, CROs (contract research organisations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials.
Medidata will open access to its Patient Insights Program as part of a new offering to incorporate a patient-centric approach to the design and development of clinical trial protocols and technologies, according to a statement.
The Patient Insights Program provides access to Medidata’s experienced and diverse Patient Insights Board, using innovative workshops called design studios to guide the creation of protocols and patient-facing solutions to improve clinical trial experiences, expedite clinical trial delivery timelines, and bring therapies to market faster.
“Medidata is the first company to institute a formal process of infusing the patient perspective into the software development life cycle to create technical solutions improving the overall patient experience,” said vice president, Patient Engagement at Medidata, Alicia Staley.
“We are opening up access to this programme to ultimately make clinical trials an option for more people, including those historically left behind by clinical trials.”
‘Patient centricity’ has been a buzzword for nearly a decade but most clinical studies are designed with little to no direct input from the patients/caregivers that are expected to enroll in and adhere to a clinical research study.
Patient engagement has mostly been limited to sporadic and superficial sessions, with little impact on reducing patient burden or improving enrolment, retention, and experience.
The Medidata Patient Insights team has run over 20 design studios to provide feedback and insights into Medidata products.
Medidata’s Patient Centricity by Design is a formal methodology by which the patient perspective is infused into the software development life cycle.
More details at www.medidata.com.
-- BERNAMA
No comments:
Post a Comment